Company to Host Pre-Eminent Lap-Band® Surgeon Advocates For a Three-Day Seminar, August 1-3, 2025 ...

For patients with type 2 diabetes, glucagon-like peptide-1 receptor agonists (GLP-1 RAs) are associated with an increased risk for gastroesophageal reflux disease (GERD) and its complications compared ...

Doctors around the world have been hailing "miracle" medications that make weight loss far easier, but new research suggests ...

Veru Inc. (NASDAQ: VERU), a late clinical stage biopharmaceutical company focused on developing innovative medicines for the ...

Gilles Andrier, CEO of Givaudan discusses HY earnings, and outlines areas of growth within the business despite ongoing ...